BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 7826295)

  • 1. Surgical management of submacular hemorrhage. A series of 47 consecutive cases.
    Ibanez HE; Williams DF; Thomas MA; Ruby AJ; Meredith TA; Boniuk I; Grand MG
    Arch Ophthalmol; 1995 Jan; 113(1):62-9. PubMed ID: 7826295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.
    Thompson JT; Sjaarda RN
    Trans Am Ophthalmol Soc; 2005; 103():98-107; discussion 107. PubMed ID: 17057793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.
    Hattenbach LO; Klais C; Koch FH; Gümbel HO
    Ophthalmology; 2001 Aug; 108(8):1485-92. PubMed ID: 11470706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
    Haupert CL; McCuen BW; Jaffe GJ; Steuer ER; Cox TA; Toth CA; Fekrat S; Postel EA
    Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage.
    Lewis H
    Am J Ophthalmol; 1994 Nov; 118(5):559-68. PubMed ID: 7977569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid.
    Kamei M; Tano Y; Maeno T; Ikuno Y; Mitsuda H; Yuasa T
    Am J Ophthalmol; 1996 Mar; 121(3):267-75. PubMed ID: 8597269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
    Hassan AS; Johnson MW; Schneiderman TE; Regillo CD; Tornambe PE; Poliner LS; Blodi BA; Elner SG
    Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of submacular hemorrhage associated with idiopathic polypoidal choroidal vasculopathy.
    Shiraga F; Matsuo T; Yokoe S; Takasu I; Okanouchi T; Ohtsuki H; Grossniklaus HE
    Am J Ophthalmol; 1999 Aug; 128(2):147-54. PubMed ID: 10458169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative use of tissue plasminogen activator for large submacular hemorrhage.
    Chaudhry NA; Mieler WF; Han DP; Alfaro VD; Liggett PE
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):176-80. PubMed ID: 10100249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Submacular hemorrhage removal.
    Lim JI; Drews-Botsch C; Sternberg P; Capone A; Aaberg TM
    Ophthalmology; 1995 Sep; 102(9):1393-9. PubMed ID: 9097779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S; Chow DR; Packo KH; MacCumber MW; Awh CC
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
    Kimura S; Morizane Y; Hosokawa M; Shiode Y; Kawata T; Doi S; Matoba R; Hosogi M; Fujiwara A; Inoue Y; Shiraga F
    Am J Ophthalmol; 2015 Apr; 159(4):683-9. PubMed ID: 25555798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of submacular hemorrhage associated with retinal arterial macroaneurysms.
    Humayun M; Lewis H; Flynn HW; Sternberg P; Blumenkranz MS
    Am J Ophthalmol; 1998 Sep; 126(3):358-61. PubMed ID: 9744368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal macular electroretinogram before and after drainage of macular subretinal hemorrhage.
    Terasaki H; Miyake Y; Kondo M; Tanikawa A
    Am J Ophthalmol; 1997 Feb; 123(2):207-11. PubMed ID: 9186126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Kung YH; Wu TT; Hong MC; Sheu SJ
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreous recombinant tissue plasminogen activator and gas to treat submacular hemorrhage in age-related macular degeneration.
    Tsai SC; Lin JM; Chen HY
    Kaohsiung J Med Sci; 2003 Dec; 19(12):608-16. PubMed ID: 14719558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in the clinical course of submacular hemorrhage.
    Berrocal MH; Lewis ML; Flynn HW
    Am J Ophthalmol; 1996 Oct; 122(4):486-93. PubMed ID: 8862044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.
    Inoue M; Shiraga F; Shirakata Y; Morizane Y; Kimura S; Hirakata A
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1663-9. PubMed ID: 25418034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of macular hole and submacular hemorrhage in the same eye.
    Bakri SJ; Sears JE; Lewis H
    Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):609-11. PubMed ID: 16871381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.